SEC Form 4 · accession 0001179110-18-003294

Teladoc Health, Inc. · TDOC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Executive VP, COO and CFO

Period of report

Feb 28, 2018

Accepted (ET)

Mar 2, 2018 · 5:03 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001477449

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Feb 28, 2018	M	1,002	$1.67	A	98,960	D
Common Stock^F1	Feb 28, 2018	M	4,793	—	A	103,753	D
Common Stock^F3	Feb 28, 2018	S	100,000	$39.60	D	3,753	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F4	$1.67	Feb 28, 2018	M	1,002	D	—	Dec 11, 2023	Common Stock	1,002	16,022	D
Restricted Stock Units^F1,F5	—	Feb 28, 2018	M	4,793	D	—	May 25, 2027	Common Stock	4,793	14,377	D

F1Restricted stock units convert into common stock on a one-for-one basis.
F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on September 14, 2017.
F3Represents the weighted average price of transactions ranging from $37.05 to $40.95. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares [purchased/ sold] at each separate price.
F4The option vested as to 25% of the shares on December 11, 2014. The remainder of the shares vest in 36 equal monthly installments thereafter.
F5On May 25, 2017, the reporting person was granted 19,170 restricted stock units, vesting in four equal annual installments beginning on March 3, 2018.